Log In
BCIQ
Print this Print this
 

Tardoxal, Pyridoxal 5'-phosphate (formerly Avastrem)

  Manage Alerts
Collapse Summary General Information
Company Medicure Inc.
DescriptionNaturally occurring small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHyperkinetic movement disorder
Indication DetailsTreat moderate to severe tardive dyskinesia (TD); Treat tardive dyskinesia with schizophrenia or schizoaffective disorders
Regulatory Designation U.S. - Fast Track (Treat moderate to severe tardive dyskinesia (TD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today